<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mondatore D</submitter><funding>University of Milan</funding><funding>Fondazione Regionale della Ricerca Biomedica</funding><pagination>ofac046</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8918388</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>People with HIV are at increased risk of human papillomavirus (HPV) disease progression, given the persistence of immune activation and residual inflammation despite effective combination antiretroviral therapy (cART). Whether a low CD4:CD8 T-cell ratio, known to mirror peripheral immune dysfunction, is associated with squamous intraepithelial lesions (SILs) is unknown.&lt;h4>Methods&lt;/h4>This was a retrospective cohort study on cART-treated HIV-positive subjects undergoing screening for HPV-related dysplasia (anal/cervical cytology and HPV genotyping). SIL was defined as the presence of either atypical squamous cells of undetermined significance (ASCUS), low-grade SILs, or high-grade SILs. Demographic and viro-immunological parameters (T-cell count, CD4:CD8 T-cell ratio, CD</pubmed_abstract><journal>Open forum infectious diseases</journal><pubmed_title>Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects.</pubmed_title><pmcid>PMC8918388</pmcid><funding_grant_id>073</funding_grant_id><pubmed_authors>Augello M</pubmed_authors><pubmed_authors>Pisani Ceretti A</pubmed_authors><pubmed_authors>Marchetti GC</pubmed_authors><pubmed_authors>Mondatore D</pubmed_authors><pubmed_authors>Tincati C</pubmed_authors><pubmed_authors>d'Arminio Monforte A</pubmed_authors><pubmed_authors>Giovenzana M</pubmed_authors><pubmed_authors>Bono V</pubmed_authors><pubmed_authors>Opocher E</pubmed_authors><pubmed_authors>Bai F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects.</name><description>&lt;h4>Background&lt;/h4>People with HIV are at increased risk of human papillomavirus (HPV) disease progression, given the persistence of immune activation and residual inflammation despite effective combination antiretroviral therapy (cART). Whether a low CD4:CD8 T-cell ratio, known to mirror peripheral immune dysfunction, is associated with squamous intraepithelial lesions (SILs) is unknown.&lt;h4>Methods&lt;/h4>This was a retrospective cohort study on cART-treated HIV-positive subjects undergoing screening for HPV-related dysplasia (anal/cervical cytology and HPV genotyping). SIL was defined as the presence of either atypical squamous cells of undetermined significance (ASCUS), low-grade SILs, or high-grade SILs. Demographic and viro-immunological parameters (T-cell count, CD4:CD8 T-cell ratio, CD</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-19T12:55:14.642Z</modification><creation>2025-04-19T12:55:14.642Z</creation></dates><accession>S-EPMC8918388</accession><cross_references><pubmed>35291446</pubmed><doi>10.1093/ofid/ofac046</doi></cross_references></HashMap>